Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 26928

1.

The role of radiotherapy in bone metastases: A critical review of current literature.

Kougioumtzopoulou A, Zygogianni A, Liakouli Z, Kypraiou E, Kouloulias V.

Eur J Cancer Care (Engl). 2017 Jun 20. doi: 10.1111/ecc.12724. [Epub ahead of print] Review.

PMID:
28631284
2.

New insights into human farnesyl pyrophosphate synthase inhibition by second-generation bisphosphonate drugs.

Fernández D, Ramis R, Ortega-Castro J, Casasnovas R, Vilanova B, Frau J.

J Comput Aided Mol Des. 2017 Jun 19. doi: 10.1007/s10822-017-0034-5. [Epub ahead of print]

PMID:
28631130
3.

Chronic Recurrent Multifocal Osteomyelitis: A Case Report with Atypical Presentation.

Figueiredo MP, Pato M, Amaral F.

J Orthop Case Rep. 2017 Jan-Feb;7(1):75-78. doi: 10.13107/jocr.2250-0685.69.

PMID:
28630846
4.

Osteogenesis imperfecta - A clinical update.

Tournis S, Dede AD.

Metabolism. 2017 Jun 8. pii: S0026-0495(17)30158-0. doi: 10.1016/j.metabol.2017.06.001. [Epub ahead of print]

PMID:
28625337
5.

Do topical applications of bisphosphonates improve bone formation in oral implantology? A systematic review.

Lozano-Carrascal N, Salomó-Coll O, Hernández-Alfaro F, Gehrke SA, Gargallo-Albiol J, Calvo-Guirado JL.

Med Oral Patol Oral Cir Bucal. 2017 Jun 18:0. [Epub ahead of print]

6.

Osteoporosis in Children with Chronic Illnesses: Diagnosis, Monitoring, and Treatment.

Grover M, Bachrach LK.

Curr Osteoporos Rep. 2017 Jun 15. doi: 10.1007/s11914-017-0371-2. [Epub ahead of print] Review.

PMID:
28620868
7.

Osteoporosis Management in Ankylosing Spondylitis.

Hinze AM, Louie GH.

Curr Treatm Opt Rheumatol. 2016 Dec;2(4):271-282. doi: 10.1007/s40674-016-0055-6. Epub 2016 Oct 5.

PMID:
28620575
8.

Anakinra in a Cohort of Children with Chronic Nonbacterial Osteomyelitis.

Pardeo M, Pires Marafon D, Messia V, Garganese MC, De Benedetti F, Insalaco A.

J Rheumatol. 2017 Jun 15. pii: jrheum.160690. doi: 10.3899/jrheum.160690. [Epub ahead of print]

PMID:
28620059
9.

Hydroxyapatite as a nanomaterial for advanced tissue engineering and drug therapy.

Tuukkanen J, Nakamura M.

Curr Pharm Des. 2017 Jun 15. doi: 10.2174/1381612823666170615105454. [Epub ahead of print]

PMID:
28619003
10.

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.

Dhesy-Thind S, Fletcher GG, Blanchette PS, Clemons MJ, Dillmon MS, Frank ES, Gandhi S, Gupta R, Mates M, Moy B, Vandenberg T, Van Poznak CH.

J Clin Oncol. 2017 Jun 20;35(18):2062-2081. doi: 10.1200/JCO.2016.70.7257. Epub 2017 Mar 6.

PMID:
28618241
11.

Prevention of osteoporotic refractures in regional Australia.

Davidson E, Seal A, Doyle Z, Fielding K, McGirr J.

Aust J Rural Health. 2017 Jun 15. doi: 10.1111/ajr.12355. [Epub ahead of print]

PMID:
28618161
12.

Hyperphosphatemia in a patient with spinal cord injury who received etidronate for the treatment of heterotopic ossification.

Taravati S, Cinar E, Akkoc Y.

Spinal Cord Ser Cases. 2017 Jun 8;3:17032. doi: 10.1038/scsandc.2017.32. eCollection 2017.

PMID:
28616259
13.

Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States.

Qian Y, Bhowmik D, Bond C, Wang S, Colman S, Hernandez RK, Cheng P, Intorcia M.

Cancer Med. 2017 Jun 14. doi: 10.1002/cam4.1075. [Epub ahead of print]

14.

Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment.

Shay G, Tauro M, Loiodice F, Tortorella P, Sullivan DM, Hazlehurst LA, Lynch CC.

Oncotarget. 2017 May 23. doi: 10.18632/oncotarget.18103. [Epub ahead of print]

15.

Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.

Caparrotti F, Huang SH, Lu L, Bratman SV, Ringash J, Bayley A, Cho J, Giuliani M, Kim J, Waldron J, Hansen A, Tong L, Xu W, O'Sullivan B, Wood R, Goldstein D, Hope A.

Cancer. 2017 Jun 13. doi: 10.1002/cncr.30803. [Epub ahead of print]

PMID:
28608925
16.

Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients.

Dalle Carbonare L, Mottes M, Malerba G, Mori A, Zaninotto M, Plebani M, Dellantonio A, Valenti MT.

Int J Mol Sci. 2017 Jun 13;18(6). pii: E1261. doi: 10.3390/ijms18061261.

17.

Aggressive primary hepatic epithelioid hemangioendothelioma: a case report and literature review.

Afrit M, Nasri M, Labidi S, Mejri N, El Benna H, Boussen H.

Cancer Biol Med. 2017 May;14(2):187-190. doi: 10.20892/j.issn.2095-3941.2016.0105.

18.

Tc-99m Radiolabeled Alendronate Sodium Microemulsion: Characterization and Permeability Studies across Caco-2 Cells.

Elitez Y, Ekinci M, Ilem-Ozdemir D, Gundogdu E, Asikoglu M.

Curr Drug Deliv. 2017 Jun 12. doi: 10.2174/1567201814666170613082752. [Epub ahead of print]

PMID:
28606033
19.

Synthesis and evaluation of symmetric acyclic nucleoside bisphosphonates as inhibitors of the Plasmodium falciparum, Plasmodium vivax and human 6-oxopurine phosphoribosyltransferases and the antimalarial activity of their prodrugs.

Špaček P, Keough DT, Chavchich M, Dračínský M, Janeba Z, Naesens L, Edstein MD, Guddat LW, Hocková D.

Bioorg Med Chem. 2017 May 24. pii: S0968-0896(17)30721-6. doi: 10.1016/j.bmc.2017.05.048. [Epub ahead of print]

PMID:
28601510
20.

The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation.

Cianferotti L, Bertoldo F, Carini M, Kanis JA, Lapini A, Longo N, Martorana G, Mirone V, Reginster JY, Rizzoli R, Brandi ML.

Oncotarget. 2017 May 18. doi: 10.18632/oncotarget.17980. [Epub ahead of print] Review.

Supplemental Content

Loading ...
Support Center